Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Qualcomm CFO William Keitel To Retire - Quick Facts

RELATED NEWS
Trade QCOM now with 

Qualcomm Inc. (QCOM: Quote) announced that William Keitel has decided to retire as executive vice president and chief financial officer. George Davis, currently executive vice president and chief financial officer of Applied Materials, Inc., will replace Keitel effective March 11, 2013.

The company said that Keitel will continue as chief financial officer until that time, and will then assist with the transition and serve as special advisor to the CEO for the remainder of the calendar year. Davis will report to Paul Jacobs, chairman and chief executive officer of Qualcomm.

Davis served as a chief financial officer for more than six years. During his nearly 13-year tenure with Applied Materials, Davis held several leadership roles including corporate treasurer and head of the Corporate Business Development group, where he was responsible for merger and acquisition activities, strategic planning, and management of the Company's venture investments. In addition to his finance and business development oversight, George also had responsibility for the company's activities in information technology, government affairs and corporate relations.

Register
To receive FREE breaking news email alerts for Qualcomm Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.